CLARIANT ADR 1/SF 4 (CLRS) - Total Liabilities
Based on the latest financial reports, CLARIANT ADR 1/SF 4 (CLRS) has total liabilities worth €3.69 Billion EUR (≈ $4.31 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check CLARIANT ADR 1/SF 4 (CLRS) asset resilience to evaluate the company's liquid asset resilience ratio.
CLARIANT ADR 1/SF 4 - Total Liabilities Trend (2021–2025)
This chart illustrates how CLARIANT ADR 1/SF 4's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of CLARIANT ADR 1/SF 4.
CLARIANT ADR 1/SF 4 Competitors by Total Liabilities
The table below lists competitors of CLARIANT ADR 1/SF 4 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
|
China | CN¥631.40 Million |
|
Sportradar Group AG
NASDAQ:SRAD
|
USA | $1.78 Billion |
|
Shufersal
TA:SAE
|
Israel | ILA11.23 Billion |
|
Ansell Limited
F:PD1A
|
Germany | €1.34 Billion |
|
Wuhan Yangtze Communication Industry Group Co Ltd
SHG:600345
|
China | CN¥1.06 Billion |
|
Sunway Construction Group Bhd
KLSE:5263
|
Malaysia | RM3.68 Billion |
|
Procter & Gamble Hygiene and Health Care Limited
NSE:PGHH
|
India | Rs10.50 Billion |
|
ZIM Integrated Shipping Services Ltd.
F:2SV
|
Germany | €6.98 Billion |
Liability Composition Analysis (2021–2025)
This chart breaks down CLARIANT ADR 1/SF 4's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See CLARIANT ADR 1/SF 4 balance sheet quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.64 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.82 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.63 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CLARIANT ADR 1/SF 4's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CLARIANT ADR 1/SF 4 (2021–2025)
The table below shows the annual total liabilities of CLARIANT ADR 1/SF 4 from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €3.69 Billion ≈ $4.31 Billion |
-1.78% |
| 2024-12-31 | €3.76 Billion ≈ $4.39 Billion |
+18.60% |
| 2023-12-31 | €3.17 Billion ≈ $3.70 Billion |
-13.82% |
| 2022-12-31 | €3.67 Billion ≈ $4.30 Billion |
-18.22% |
| 2021-12-31 | €4.49 Billion ≈ $5.25 Billion |
-- |
About CLARIANT ADR 1/SF 4
Clariant AG develops, manufactures, distributes, and sells specialty chemicals in Switzerland, Europe, the Middle East, Africa, the United States, and the Asia Pacific. It operates through Care Chemicals, Catalysts, and Adsorbents & Additives segments. The Care Chemicals segment offers personal and home care, crop solutions, industrial applications, base chemicals, oil services, and mining soluti… Read more